3M (NYSE:MMM) announced that it created a new leadership role to promote diversity and more, with James Momon assuming that position. Momon will join 3M on Dec. 15 as VP of equity & community and chief equity officer as 3M looks to advance diversity, inclusion, equity and social justice both inside and outside the company, according […]
Personnel Moves
Acutus appoints chief translational science officer
Acutus Medical (NSDQ:AFIB) announced that it appointed Dr. Steven Mickelsen as its chief translational science officer. Carlsbad, Calif.-base Acutus, which develops cardiac mapping technology, said in a news release that Mickelsen is set to guide the company’s vision to deliver the “most advanced electrophysiology therapeutic solutions on the market for physicians and their patients.” Mickelsen […]
Biolinq names new CEO
Wearable biosensor technology developer Biolinq announced today that it named Richard Yang as its new CEO. San Diego-based Biolinq, which develops biosensor platforms to measure continuous glucose for managing diabetes, among other clinical conditions, said in a news release that Yang is a veteran of more than 20 years with time spent at top-tier medical […]
GI Dynamics names new CEO
GI Dynamics (ASX:GID) announced that CEO & president Scott Schorer has departed and that Joseph Virgilio is assuming both roles. Virgilio, previously the company’s COO, took over as president & CEO on Nov. 2, with no changes made to his current compensation as of yet. GI Dynamics confirmed in a news release that Virgilio’s current executive […]
Imperative Care appoints new president
Imperative Care announced today that its chief operating officer, Daniel Davis, was appointed as the company’s new president. Davis is slated to oversee the growth of the company’s technology portfolio for the treatment of ischemic and hemorrhagic stroke as president, according to a news release. He will continue in his role as COO and will […]
LivaNova stock up on Street-beating Q3, CFO departing
LivaNova (NSDQ:LIVN) posted third-quarter results today that beat the consensus forecast on Wall Street, though the company still expects full-year sales between –7% and –17% on a constant-currency basis. LivaNova also announced that CFO Thad Huston will leave his position by Oct. 31 — after serving three and a half years with the company. Alex Shvartsburg, […]
ivWatch appoints new COO
Continuous IV monitoring system developer ivWatch announced that it appointed Jaclyn Lautz as its new chief operating officer. Lautz assumes the newly created position at the company, having previously led its research and development division. Her new role will include manufacturing, human resources and operations as well in an effort to drive efficiency and scalability of […]
Cynosure names EVP of R&D
Cynosure announced today that it appointed Sujat Sukthankar as its executive VP of research & product development, effective today. Westford, Mass.-based Cynosure said in a news release that Sukthankar will report to CEO Todd Tillemans and will work to enhance the company’s R&D team. “There is no better person to help drive category growth than […]
SpectraWave names new CEO
Coronary artery disease (CAD) treatment startup SpectraWave announced today that it has appointed Eman Namati as its new CEO. Bedford, Mass.-based SpectraWave is developing a medical imaging platform that uses photonics to improve CAD outcomes. Namati joins with more than a decade of experience leading the development and launch of highly technical medical imaging products, […]
Former Medtronic CEO Ishrak to retire from board
Former Medtronic CEO Omar Ishrak is resigning his spot as executive chairman of the company’s board, effective immediately, the medical device giant said in a recent SEC filing. Medtronic (NYSE:MDT) also said in the Oct. 2 filing that Ishrak will not seek re-election to the company’s board during its Dec. 11 shareholders meeting. Medtronic added that […]
Delcath names new CEO
Delcath Systems (OTC:DCTH) announced that it appointed Gerard Michel as its new CEO, effective yesterday, Oct. 1, 2020. Michel assumed the role yesterday and also was appointed as a Class I director on the company’s board of directors, with that role continuing until the expiry of his term at the company’s 2022 annual meeting of stockholders, […]
